ImetelChat

Hoping for some important news delivered during the next quarterly update on next Tuesday. While Geron can't control the timing of an FDA change in drug status (e.g. AA), I believe they would time the conference call to coincide with a Janssen decision. It will have been three months since the MF tr...

Earnings release and conference call July 31st. I always like when they say they will discuss "recent events". MENLO PARK, Calif., July 24, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (GERN) today announced that it will release its second quarter 2018 financial results after the market clos...

While we are on the subject, looks like Gilead has also filed for a combo patent:

Abstract
The disclosure describes methods for and compositions for treatment of patients having cancers expressing CYP3A enzymes by co-administration of cobicistat with an anticancer agent.

Link is on SA

This is a a very interesting article. Who would have thought that an antidepressant would have anti tumor activity. (I could see where it might help attitude at least). It just goes to show that so many compounds have been testing in the search for anti neoplastic agents (including vitamin C for Lin...

We have previously discussed the recent completion of the previously terminated (2016) Pediatric Consortium Study which was forced to close early due to unfortunate intra cerebral hemorrhages in two patients. We have discussed possible etiologies for the bleeds but mostly this was likely related to ...

OK I'm back as biopearl123, thanks to Fish Jr for his Herculean efforts to fix the problem. Lots of good stuff on SA recently especially parsing the termination of the Mayo study. If anyone wants to repost please do. Those who have had trouble registering please give it a try now. it did work for me...